Ginger delivers on-demand mental healthcare through an app offering unlimited self-guided care, 24/7 behavioral health coaching, and video therapy and psychiatry, supported by a proprietary Care Hub EMR. The company has published peer-reviewed studies in JMIR demonstrating reductions in anxiety and depression among employer populations. Over 10 million people have access to Ginger through partnerships with more than 500 employers, strategic partners, and 30 integrated health systems and health plans. Ginger reported approximately 3x revenue growth over the past year and total funding now exceeds $220 million. The company has introduced a value-based pricing model covering coaching, self-guided care, and a set number of therapy and psychiatry sessions; nearly 60% of new clients adopted this option in the last 12 months. Ginger plans to use the new funding to expand value-based offerings with multinational employers and health plans, extend reach into underserved populations via government payer relationships and nonprofits, and continue acquiring technologies and clinical services. Ginger provides on-demand mental healthcare through a care coordinator model that connects members with trained behavioral health coaches and escalates to specialists, therapy, or psychiatry for more serious conditions. The service is delivered primarily through employer-operated health insurance plans and in-network relationships with regional and national health plans such as Optum Behavioral Health, Anthem California and Aetna Resources for Living. Ginger charges companies on a per-employee, per-month basis and counts more than 200 corporate customers, including Delta Air Lines, Sanofi, Chegg, Domino’s, SurveyMonkey and Sephora. The company began as an MIT research spinout in 2011, launched on-demand care in 2016, and reports tens of thousands of active users and coverage to hundreds of thousands of employees via benefit plans. Future plans described by management include expanding partner ecosystems (including Cigna), pursuing government payers, potential direct-to-consumer offerings, and investing in automation, natural language processing and machine learning to personalize care. Ginger provides employers and healthcare partners an app-based, text-first mental health coaching service that offers immediate 24/7 responses and escalations to video therapy and psychiatry. The platform guarantees clinician time within 72 hours and reports that about 8% of users are escalated to video-based licensed clinicians. More than 200,000 people can access Ginger through employer plans, and the company is active in 25 countries including the U.K., Japan, Australia, Canada and India. Customers include CBS, Netflix, Pinterest, Sephora, Twilio, Yelp and BuzzFeed. Ginger reports that 70% of members surveyed who used the service saw a significant reduction in depression symptoms within 12 weeks. The company plans to invest the new capital to expand its data science, broaden clinical programs, grow internationally and move beyond the employer channel into health-plan distribution. Ginger.io builds behavioral health analytics tools and partners with medical institutions to integrate those analytics into care. The company works with hospitals and research centers including UCSF, Massachusetts General Hospital, Brigham and Women’s Hospital, McLean Hospital, Duke University, UC Davis and the University of Nebraska Medical Center. According to an SEC filing, Ginger.io added $20 million in Series B funding, bringing total capital raised to $28.2 million. The filing also notes Kaiser Permanente Ventures partner Dave Schulte was added to Ginger.io’s board, which the filing says usually implies the new investor led the round. Kaiser is already a partner of the startup, and the strengthened strategic relationship could help Ginger.io become more widely used in hospitals. Earlier investors named in the article include Romulus Capital, Khosla Ventures and True Ventures, and the company recently launched a grant-funded program to help low-income people suffering from depression in Utah. Ginger.io uses patients' smartphones to identify changes in behavior that may signal worsening chronic conditions, describing its service as a “check‑engine light” for healthcare. The platform is aimed at enabling hospitals to monitor patients between visits and proactively reach out to those showing warning signs. It targets monitoring for conditions such as diabetes, depression, and cardiovascular disease. Ginger.io emerged from CEO Amnol Madan's work at the MIT Media Lab and was incubated at TechStars; co‑founder Karan Singh is also a company founder. Current customers include Cincinnati Children’s Hospital’s Chronic Collaborative Care Network and the Carolinas‑based hospital system Novant. Financially, the company has raised a $6.5M Series A and has now raised a total of $8.2M.

Total raised

$213M

Funding rounds

6

Latest round

Series E

Latest activity

Mar 2021